These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22576567)

  • 1. [A Decoy Oligodeoxynucleotides therapy for allergic skin diseases].
    Yokozeki H
    Nihon Rinsho Meneki Gakkai Kaishi; 2012; 35(2):107-11. PubMed ID: 22576567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
    Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
    Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity.
    Sumi K; Yokozeki H; Wu MH; Satoh T; Kaneda Y; Takeda K; Akira S; Nishioka K
    Gene Ther; 2004 Dec; 11(24):1763-71. PubMed ID: 15306843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nucleic acid-based medication for allergic skin diseases.
    Yokozeki H
    J Dermatol Sci; 2014 Aug; 75(2):75-81. PubMed ID: 24726501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model.
    Nakamura H; Aoki M; Tamai K; Oishi M; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2002 Sep; 9(18):1221-9. PubMed ID: 12215889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of decoy oligodeoxynucleotides-based approach to renal diseases.
    Tomita N; Azuma H; Kaneda Y; Ogihara T; Morishita R
    Curr Drug Targets; 2004 Nov; 5(8):717-33. PubMed ID: 15578952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of atopic dermatitis in NC/Nga mice by topical application of CpG phosphodiester-ODN.
    Kim YS; Kim Y; Lee KJ; Kwon HJ; Kim DS; Kim TY
    Int Arch Allergy Immunol; 2007; 144(4):315-24. PubMed ID: 17671391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT6 decoy oligodeoxynucleotide (ODN)-containing ointment more potently inhibits mouse skin inflammation when formulated with ionic liquid technology than as a traditional Vaseline ointment.
    Handa Y; Ugajin T; Igawa K; Hamamoto H; Kobayashi K; Komatsuno T; Yamamoto T; Kawahara K; Yokozeki H
    Allergol Int; 2019 Jul; 68(3):380-382. PubMed ID: 30704845
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model.
    Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T
    Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide.
    Dajee M; Muchamuel T; Schryver B; Oo A; Alleman-Sposeto J; De Vry CG; Prasad S; Ruhrmund D; Shyamsundar R; Mutnick D; Mai K; Le T; Parham C; Zhang J; Komuves L; Colby T; Hudak S; McEvoy LM; Ehrhardt RO
    J Invest Dermatol; 2006 Aug; 126(8):1792-803. PubMed ID: 16628194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats].
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.
    Matsuda N; Hattori Y; Jesmin S; Gando S
    Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The decoy oligodeoxynucleotide against HIF-1α and STAT5 ameliorates atopic dermatitis-like mouse model.
    Gwon MG; Leem J; An HJ; Gu H; Bae S; Kim JH; Park KK
    Mol Ther Nucleic Acids; 2023 Dec; 34():102036. PubMed ID: 37799329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction.
    Morishita R; Sugimoto T; Aoki M; Kida I; Tomita N; Moriguchi A; Maeda K; Sawa Y; Kaneda Y; Higaki J; Ogihara T
    Nat Med; 1997 Aug; 3(8):894-9. PubMed ID: 9256281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.